$RLFTF Phase 2b/3 clinical trials, with read out d
Post# of 103036
(Total Views: 114)
Posted On: 01/27/2021 11:12:03 PM
$RLFTF Phase 2b/3 clinical trials, with read out data expected by January 28, 2021
Big Rock Partners Acquisition Corp. FORM S-4
Released: January 27, 2021
Page: 173
https://fintel.io/doc/sec-big-rock-partners-a...27-18654-7
Our first VIP-derived product - ZYESAMI (RLF-100), the NeuroRx COVID-19 Drug - was awarded Fast Track designation by the FDA in June 2020 and admitted to the Coronavirus Treatment Acceleration Program. NeuroRx is currently conducting Phase 2b/3 clinical trials, with read out data expected by January 28, 2021.
Read More: https://investorshangout.com/post/view?id=603...z6koQ5zaMp
Big Rock Partners Acquisition Corp. FORM S-4
Released: January 27, 2021
Page: 173
https://fintel.io/doc/sec-big-rock-partners-a...27-18654-7
Our first VIP-derived product - ZYESAMI (RLF-100), the NeuroRx COVID-19 Drug - was awarded Fast Track designation by the FDA in June 2020 and admitted to the Coronavirus Treatment Acceleration Program. NeuroRx is currently conducting Phase 2b/3 clinical trials, with read out data expected by January 28, 2021.
Read More: https://investorshangout.com/post/view?id=603...z6koQ5zaMp
(0)
(0)
$MJ
Scroll down for more posts ▼